title: [Psychopharmacological approach with the usage of selective serotonin reuptake inhibitors in functional dyspepsia treatment].
abstract: Objective: To assess the efficacy of selective serotonin reuptake inhibitor (SSRI) escitalopram in patients with functional dyspepsia (FD). Treatment results showed reduction of dyspeptic symptoms as well as significant decrease of anxiety and depression and improvement of quality of life in patients, who were additionally prescribed SSRI.
authors.forename: I V
authors.initials: IV
authors.lastname: Korendovych
authors.forename: A S
authors.initials: AS
authors.lastname: Svintsits'kyĭ
authors.forename: K M
authors.initials: KM
authors.lastname: Revenok
authors.forename: S O
authors.initials: SO
authors.lastname: Maliarov
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001007:Anxiety / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D015283:Citalopram / Q000627:therapeutic use*; D003863:Depression / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D005260:Female; D005756:Gastritis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D016480:Helicobacter pylori / Q000187:drug effects / Q000254:growth & development; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors